NCT00024141View on ClinicalTrials.gov

Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Primary Completion Date

September 30, 2002

Study Completion Date

January 31, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

fluorouracil

DRUG

irinotecan hydrochloride

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00024141 - Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter